cagrilintide novo nordisk Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes Novo Nordisk files for FDA

Left untreated, diabetes and obesity pose grave health risks 5 Some common risks of untreated diabetes and obesity include high blood pressure, cardiovascular disease, coronary artery disease, cancer, stroke, increased risk of mental illness, back and joint pain, and difficulty with daily functioning

Exp Gerontol

Ive previously reviewed the GLP-1 family of peptides extensively (here and here) and it seems every week there is a new potential use case, such as we recently saw for migraine and the oneAlzheimers disease that we await with a very high level of anticipation in September from the 2 large trials with semaglutide

Two common testosterone esters are cypionate and enanthate

Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors

It has shown a strong safety profile in animal research and good tolerance in human research subjects, but large-scale human clinical trials are still needed